Soluble TREM2 distinguishes neuromyelitis optica spectrum disorder from MOG antibody disease
Chuquisana, O., Spatola, M., Dinoto, A., Sepúlveda, M., Mariotto, S., Tintore, M.,…Lünemann, J. (2024). Soluble TREM2 distinguishes neuromyelitis optica spectrum … Read More
